Back to top
more

Dynatronics (DYNT)

(Delayed Data from NSDQ)

$0.56 USD

0.56
72,663

+0.02 (4.68%)

Updated Apr 22, 2024 11:54 AM ET

After-Market: $0.52 -0.04 (-6.63%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Dynatronics Corporation (DYNT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Dynatronics Corporation (DYNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dynatronics Corporation (DYNT) Reports Q4 Loss, Tops Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -85.29% and 5.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q3 Loss, Misses Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -125% and 11.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -11.43% and 9.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

IRadimed (IRMD) Surpasses Q1 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 11.11% and 4.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 6.06% and 10.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q2 Loss, Lags Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -80% and 0.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023

Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy as Inflation Clouds Prospects

The Zacks Medical - Instruments industry is growing on rising demand for digital health. SWAV, MLAB and DYNT are set to gain the most. Yet, the ongoing inflation in the form of rising freight, raw material and labor costs is an overhang.

Dynatronics Corporation (DYNT) Reports Q1 Loss, Tops Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of 33.33% and 2.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 107.19% and 10.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q4 Loss, Misses Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -11.11% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Break-Even Earnings for Q3

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of 100.00% and 0.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Dynatronics Corporation (DYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sanghamitra Saha headshot

Have Faith in Rising P/E: Play 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Orthofix (OFIX) Hits 52-Week High, Can the Run Continue?

Orthofix (OFIX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.